15
The secure, all-in-one technology platform and network specifically built for the global Healthcare Industry Healthcare Happens Here ™
The secure, all-in-one technology platform and network specifically built for the global Healthcare Industry
Healthcare Happens Here™
The Healthcare Industry needs a single all-encompassing technological solution that connects all industry participants in a secure and cost-efficient manner.
2
3
THE PROBLEM
Inadequate Data Privacy, Security,
User Identification, and
Market Transparency
Inefficient Technological Fragmentation,
Redundancy and
Non-Interoperability
Lacking an All-in-one Solution
Available from Anywhere,
on Any Device
1 2 3
4
OUR SOLUTION
Radiologex is the world’s first Medical Interactive Network (MIN)™. The Radiologex Digital Encryption Environment (R-DEE)® provides an ALL-IN-ONE technology platform ecosystem and high-speed NETWORK. R-DEE was built specifically to support the global Healthcare Industry, enabling seamless communication, productivity, and data storage.
5
OUR VALUE PROPOSITION
R-DEE connects the global Healthcare Industry
in real-time, on any web-connected device
(desktop browser/tablet/mobile), using advanced
user-authentication technology and a strict built-in
KYC protocol.
R-DEE eliminates all the major pain points while preserving immeasurable resources. As we
like to say: Healthcare Happens Here.™
Borderless.Frictionless.
Ultra fast and secure.Available on any device.
Strict DATA ownership and permissions set by the user.
Modular and built to work seamlessly with any existing
platform or infrastructure.
Elevated user experience (UX) which drastically cuts on
costs and time.
6
OUR TECHNOLOGY
Working product with existing customers/users
and network with over 4000 global nodes built.
Validated and Tested— CEHRT certification by the US Department of
Human & Health Services and ISO certified, with
patents pending.
Seamless integration into any existing IT architecture
with a secure web and mobile app-based solution.
Vendor-neutral plug-and-play compatibility enabled by CCDA, HL7 FHIR,
SOC2, and other standards built-in.
Proprietary software and blockchain architecture designed specifically for
medical industry use.
Currently being used (in UATs) with global clients
including Healthcare systems and Government
linked entities.
7
PLATFORM CAPABILITIES
STREAM Deliver and consume instructional content and training resources
FIND SERVICE Find, connect and troubleshoot with vendors and service providers
STORE DATA Transfer, analyze and process medical images
MANAGE Patient records, schedules and referrals
SETTLE Transact in any currency or seek affordable financing solutions
BUY/SELL All healthcare goods and equipment in a global market of KYC-verified users
COMMUNICATE 24/7, privately, within teams or enterprise, via text, audio or video; end-to-end encrypted and HIPAA-compliant vendors and service providers
FREEMIUM VERSION
Available for Download
8
REVENUE STREAMS
Subscription Dues
Recurring base of revenue from robust user base
Commission Fees
Marketplace and Expert module transactions
Licensing Fees
3rd-party content created & delivered on R-DEE
Network Fees
Payment settlement transactions on the network
Advertising Space
Ad sales for relevant products & services
Diversified Revenue Model driven by user growth and network effect.
9
GLOBAL HEALTHCARE MARKETTotal global healthcare-related expenditures are approximately $10 trillion.
Source: World Health Organization https://www.who.int/health-topics/health-accounts
MEDICAL DEVICES
$521 Billion
MEDICAL EQUIPMENT & SUPPLIES
$445 Billion
HEALTHCARE INFORMATION SYSTEMS
$100 Billion
MEDICAL IMAGING
$40 Billion
TELEMEDICINE $30 Billion
MEDICAL EQUIPMENT MAINTENANCE
$17.5 Billion
NORTH AMERICA
$4 Trillion
LATIN AMERICA
$400 Billion
WESTERN EUROPE
$1 Trillion
MIDDLE EAST & AFRICA
$200 Billion
ASIA & AUSTRALIA
$2 Trillion
10
CUSTOMER BASE POTENTIAL
There are over 70 million people connected and affiliated within the Healthcare Industry,all of whom are potential users of R-DEE*
*DELOITTE HEALTHCARE INDUSTRY 2020
11
WHY NOW
Younger demographic
of healthcare workers
Emerging Web 3.0 and wide-scale
broadband such as 5G
Rapidly rising need for
remote work
Increased emphasis
on enhanced security (hacks/ddos/phishing attacks)
12
PRODUCT TRACTION
Aadi Medi Solutions
Aamal Medical W.L.L
Ain Shams University Hospital
Al Kamali Group of Companies
Al Safwa Radiology Center
Al- Jamhorry General Hospital, Iraq
AL- SARAYA Medical Supplies
Anwar Surgicals
Arabstars
Canon Medical Systems
Change Healthcare
Community Medical Center
D Watson Group of Pharmacies
Digital Displays & Devices
Edusoft Healthcare Pvt. Ltd.
EilafCare Medical Supplies
EmergiCare Golden Oscar Scientific Equipment Trading
Harmony Medical Solutions
Hongrays
IIEMS
Jahed International Medical Clinic
Kannan Multispeciality Hospital
KBM Engineering - Integrated Healthcare Solutions
KD Global LTD
LIMSLorenz Medical Supplies
Medville Systems LtdMeril Inc.
MidlandLead
Osseous Surgicals Panorama Medical Centre
Pearl Pharma
PGM
Photon Technologies LLC
Respro Care
Sfast
Sino Pharma Group
Stryker
Suzhou Sunmed Co. Ltd
Tengri Medical
The LAB laboratory specialist
Union Diagnostic & Clinical Services Plc.
Unix Med
W.N.W Jeppeson
Wasiq Enterprises
Current Users and Interested Groups.
13
SECURITY TOKEN OFFERING (THE INVESTMENT OPPORTUNITY)
Our Security Token Offering (“STO”) is LIVE and OPEN NOW with a limited
number of security interest “Tokens” available for purchase, symbol “RDG”.
RDG security interest holders are entitled to
distributions via contractual participation right
against 25% of revenues generated by
Radiologex, including a 20% buy out trigger
for the “Token” holders.*
RDG preferred equity shares are tradable on
digital asset exchanges, potentially providing
investors with liquidity that is not typically
available to investors in start-up companies.
Fully SEC-compliant security offering.
Total supply of RDG preferred equity shares fixed
at 100 million, with per-share face value of $1.00
(at initial Round 1 launch).
Easy to use investment dashboard online, regis-
ter, credential, and invest in minutes. Distributions
are airdopped automatically into your wallet.
Projected 5 year ROI of 20x to 60x**.
Investor Information
*Pursuant to prospective buyout of the tokens triggered via a sale or IPO of LK Group, Inc., or termination of the Intercompany Agreement between Radiologex Technologies, LLC and LK Group, Inc., whichever occurs first. If a buyout of the RDG security tokens is triggered, 100% of issued tokens are bought out at a buyout price that is defined as 20% of the sale price or third-party enterprise valuation of LK Group, Inc.
***Full financial models available upon request. Non-stock securities bearing a contractual interest in Radiologex Technologies, LLC revenue.
SEC REGISTERED TRANSFER AGENT
CONTACT US
www.radiologex.com
16460 Bake Parkway Irvine CA 92618 USA
(800) 640-2198
THIS SUMMARY HAS BEEN PREPARED FOR DISTRIBUTION TO A LIMITED NUMBER OF PERSONS TO ASSIST THEM IN EVALUATING A PROPOSED INVESTMENT IN THE COMPANY. BY ACCEPTING THIS SUMMARY, THE RECIPIENT ACKNOWLEDGES AND AGREES THAT: (I) THIS SUMMARY CONTAINS CONFIDENTIAL AND PROPRIETARY INFORMATION THAT WILL BE USED ONLY FOR PURPOSES OF EVALUATING A POTENTIAL INVESTMENT IN THE OFFERING; (II) WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, THE RECIPIENT WILL NOT REPRODUCE THIS SUMMARY, IN WHOLE OR IN PART, OR DIRECTLY OR INDIRECTLY DISCLOSE OR PERMIT ITS AGENTS TO DISCLOSE ANY INFORMATION CONTAINED IN THIS SUM-MARY WITHOUT THE PRIOR WRITTEN CONSENT OF THE COMPANY; (III) WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IF THE RECIPIENT DOES NOT WISH TO PURSUE THIS MATTER, THEY WILL RETURN THIS SUMMARY TO THE COMPANY AS SOON AS POSSIBLE, TOGETHER WITH ANY OTHER MATERIAL RELATING TO THE OFFERING THAT THE RECIPIENT MAY HAVE RECEIVED FROM THE COMPANY, OR ANY OTHER PARTY. The summary description of an investment opportunity (the “Opportunity”) to be formed by Radiologex Technologies, LLC (along with its affiliates, the “Company”) included herein, and any other materials provided to you, are intended only for discussion purposes and are not intended as an offer to buy or a solicitation of an offer to sell any security and should not be relied upon by you in evaluating the merits of investing in any securities. These materials are not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use is contrary to local law or regulation. Any offering made in association with this Summary will only be made pursuant to the relevant formal Offering Agreements, together with the current financial statements of the company, and a relevant subscription application, all of which must be read in their entirety. No offer to purchase interests will be made or accepted prior to receipt by an offeree of these documents and the completion of all appropriate documentation. Neither the Securities and Exchange Commission (SEC) nor any state securities commission has approved or disapproved of the Opportunity de-scribed herein, or passed upon the adequacy or accuracy of this document. All investors must be “accredited investors” and/or “qualified purchasers” as defined in the securities laws before they can invest in the Opportunity. This presentation is not an advertisement and is not intended for public use or distribution and is intended exclusively for the use of the person to whom it has been delivered by the Company.
